Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial

By Krajnik G.   Wein W.   Greil R.   Marhold F.   Mohn-Staudner A.   Kummer F.   Malayeri R.   Zochbauer-Muller S.   Huber H.   Pirker R.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1977-1980

Elsevier

Access to resources Recommend Favorite

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Benk J.   Chemaissani A.   Scholtze J.   Lorenz C.   Niestroy A.   Dalhoff K.   Muller T.   Walter T.   Durk H.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 583-590

Elsevier

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite

Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter

By Juergens Rosalyn   Brahmer Julie   Ettinger David  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 621-629

Springer Publishing Company

Access to resources Recommend Favorite

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine

By        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 6, 2012-01 ,pp. : 1035-1038

Spandidos Publications

Access to resources Recommend Favorite